Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04869917 · ClinicalTrials.gov registry record · NA

Behavioral Nudges for Diabetes Prevention (BEGIN) Trial in Primary Care

A NA study of PreDiabetes, sponsored by Northwestern University.

Active
Registry status
NA
Development phase
960
Enrollment target
1
Study location

NCT04869917: Active NA study of PreDiabetes, sponsored by Northwestern University.

NCT04869917 is a NA study of PreDiabetes that is active but no longer recruiting, run by Northwestern University. The registered enrollment target is 960 participants, above the 695-participant average among 149 other PreDiabetes trials with a reported enrollment target (38% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04869917, a NA study of PreDiabetes, is active but no longer recruiting, sponsored by Northwestern University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
960 participants
Enrollment target
1
Study location

Study Summary

A large body of research has demonstrated that intensive lifestyle interventions and metformin are effective treatments to prevent or delay diabetes among high-risk adults, yet neither treatment is routinely used in practice. The Behavioral Nudges for Diabetes Prevention (BEGIN) Trial will test two low-touch interventions designed to motivate adoption of these treatments to prevent diabetes. Given that 38% of U.S. adults have prediabetes, the proposed study has potential for large public health impact by testing pragmatic, scalable, and sustainable approaches based in primary care to promote evidence-based treatment for this common condition.

Primary Outcome

Mean differences in weight (lbs) between treatment arms will be evaluated using mixed models adjusted for clinic site, time between visits, sex, age, race/ethnicity, and baseline cardiometabolic markers

Conditions Studied

Interventions

  • BEHAVIORAL Usual Care
  • BEHAVIORAL Decision Aid intervention
  • BEHAVIORAL Text Messaging intervention

Study Locations (1)

Illinois

  • Northwestern University - Chicago

Trial Details

FieldValue
Enrollment Target 960 participants
Start Date 2022-03-21
Est. Completion 2026-09-01
Phase NA
Northwestern University

1,209 total trials

What the registry record for NCT04869917 still lists

NCT04869917 is an interventional study that assigns participants to a tested intervention. The registered 960 participants enrollment target is mid-sized for trials with a published cap, above the 695-participant average among 149 other PreDiabetes trials with a reported enrollment target (38% higher).

The record links to 1 condition, with PreDiabetes appearing as the primary indexed condition, and to 3 interventions - of which Usual Care is the first listed.

NCT04869917 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT04869917 about?

NCT04869917 is a clinical study titled "Behavioral Nudges for Diabetes Prevention (BEGIN) Trial in Primary Care". A large body of research has demonstrated that intensive lifestyle interventions and metformin are effective treatments to prevent or delay diabetes among high-risk adults, yet neither treatment is routinely used in practice. The Behavioral Nudges for Diabetes Prevention (BEGIN) Trial will test two ...

What is the current status of trial NCT04869917?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 960 participants. The study started on 2022-03-21. Estimated completion is 2026-09-01.

What conditions does trial NCT04869917 study?

This clinical trial studies the following conditions: PreDiabetes.

What interventions are being tested in trial NCT04869917?

The interventions under investigation include: Usual Care (BEHAVIORAL), Decision Aid intervention (BEHAVIORAL), Text Messaging intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT04869917?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04869917 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for PreDiabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04869917's enrollment target sits among peer trials

960 13th of 149 higher than 137 of 149 other PreDiabetes trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other PreDiabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04726241 · 960 participants · Phase 1

    The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

  • NCT05142384 · 960 participants · NA

    ICBT (Internet Based Cognitive Behavioral Therapy) for Maternal Depression: Community Implementation in Head Start

  • NCT05178498 · 960 participants

    Impact of Dietary Inflammatory Potential on Breast Cancer Risk

  • NCT05946629 · 960 participants · NA

    SELUTION 4 De Novo Small Vessel IDE Trial

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04869917, the US trial registry maintained by the National Library of Medicine. NCT04869917 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.